Prestige BioPharma Limited (KRX:950210)
South Korea · Delayed Price · Currency is KRW 13,020
-190 (-1.44%)
At close: Oct 2, 2025
Prestige BioPharma Market Cap
Prestige BioPharma has a market cap or net worth of 156.49 billion as of October 6, 2025. Its market cap has decreased by -4.96% in one year.
Market Cap
156.49B
Enterprise Value
224.26B
Revenue
14.33B
Ranking
n/a
PE Ratio
35.17
Stock Price
13,020.00
Market Cap Chart
Since May 28, 2021, Prestige BioPharma's market cap has decreased from 360.58B to 156.49B, a decrease of -56.60%. That is a compound annual growth rate of -17.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2025 | 156.49B | -13.83% |
| Dec 30, 2024 | 181.61B | 59.39% |
| Dec 28, 2023 | 113.94B | 29.33% |
| Dec 29, 2022 | 88.10B | -64.84% |
| Dec 30, 2021 | 250.60B | -30.50% |
| May 28, 2021 | 360.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.81T |
| Celltrion | 38.64T |
| ALTEOGEN | 25.22T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,144.58B |
| Peptron | 7,006.86B |
| PharmaResearch | 5,714.31B |
| LigaChem Biosciences | 5,545.53B |